Key result
NT-proBNP above ~270 pg/mL identifies abnormal LV dimensions or depressed systolic function in nonagenarians.
Why the study?
Does plasma NT-proBNP measurement accurately exclude echocardiographic cardiac abnormalities in well-functioning nonagenarians?
Cross-Sectional (n=80)
Single-blind
No
Does plasma NT-proBNP measurement accurately exclude echocardiographic cardiac abnormalities in well-functioning nonagenarians?
Effect estimate: AUC 0.75 (95% CI 0.64-0.85)
NT-proBNP can be used to exclude echocardiographic abnormalities in well-functioning nonagenarians and help guide referrals for further cardiovascular examination.
May aid LV abnormality detection in nonagenarians; leaves open prospective validation before guiding referrals.
BACKGROUND: In the elderly the diagnosis of chronic heart failure is often challenging and the availability of echocardiography can be limited. Plasma levels of NT-proBNP are valuable tools to diagnose patients with heart failure. However, the performance of this biomarker to detect cardiac abnormalities in the very elderly remains unclear. The aims of this study were to investigate the relation between NT-proBNP and cardiac abnormalities and to evaluate the use of NT-proBNP to exclude structural and functional cardiac abnormalities in a community-based sample of "well-functioning" nonagenarians. METHODS: A diagnostic cross-sectional study embedded within the Leiden 85-plus Study in the municipality of Leiden, the Netherlands. Plasma NT-proBNP levels were measured and 2-dimensional echocardiography was performed in a subgroup of 80 well-functioning nonagenarians. Linear regression analysis was used to explore the relation between NT-proBNP and cardiac abnormalities and ROC curve analysis was used to assess the performance of NT-proBNP to exclude cardiac abnormalities. The upper limit of the lowest tertile of NT-proBNP was used as a cut-off value. RESULTS: NT-proBNP levels were associated with abnormal left ventricular (LV) dimensions, LV systolic and diastolic function, left atrial enlargement and valvular heart disease. LV mass, E/A ratio and degree of aortic regurgitation were identified as independent predictors of NT-proBNP. NT-proBNP levels were higher with greater number of echocardiographic abnormalities (P < 0.001). A cut-off level of 269.5 pg/mL identified patients with abnormal LV dimensions or depressed LV systolic function (sensitivity 85%, negative predictive value (NPV) 77%, area under the curve 0.75 (95% CI 0.64-0.85)). In addition, high NPV were found for LV systolic dysfunction, left atrial enlargement, severe valvular heart disease and pulmonary hypertension. The test performance of NT-proBNP to exclude any echocardiographic abnormality showed a sensitivity of 82% and a NPV of 65%. CONCLUSIONS: In this convenience sample of well-functioning nonagenarians NT-proBNP was related to a wide variety of functional and structural echocardiographic abnormalities. Moreover, NT-proBNP could be used to exclude echocardiographic abnormalities in well-functioning nonagenarians and might be used to indicate who needs to be referred for further cardiovascular examination.
No takes yet. Share an insight, caveat, or question.
Vaes et al. (2010) conducted a cross-sectional in Cardiac abnormalities (n=80). Plasma NT-proBNP levels vs. Echocardiography (reference standard) was evaluated on Detection of abnormal left ventricular dimensions or depressed left ventricular systolic function (AUC 0.75, 95% CI 0.64-0.85). A plasma NT-proBNP cut-off level of 269.5 pg/mL identified 90-year-old patients with abnormal left ventricular dimensions or depressed systolic function with an area under the curve of 0.75.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: